Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
OBOrchestra BioMed Holdings, Inc. logo

Orchestra BioMed Holdings, Inc. (OBIO)

NASDAQ Global Market · Currency in USD
$5.59 ▲ +0.12 (+2.19%)
At close: Oct 23, 4:00 PM ET. Market closed.
$5.61 ▲ +0.02 (+0.36%)
Pre-market: Oct 26, 6:45 AM ET

Summary

Previous Close
$5.47
Open
$5.62
Day's Range
$5.50 – $5.66
52 Week Range
$3.46 – $6.50
Volume
262,034
Avg. Volume
360,934
Market Cap
$335.99M
Beta (5Y Monthly)
0.52
PE Ratio (TTM)
--
EPS (TTM)
-$0.93
Earnings Date
Nov 9, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$10.75

Profile: Orchestra BioMed Holdings, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
86
CEO
David Hochman

Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures.

Earnings

Next report: Mon, Nov 9, 2026
EPS estimate -$0.40 · Revenue est. $129.43K
DateEst.Actual
Aug 10, 2026-$0.39-$0.38Beat
May 12, 2026-$0.40-$0.33Beat
Mar 12, 2026-$0.38$0.12Beat
Nov 10, 2025-$0.38-$0.40Miss
Aug 12, 2025-$0.51-$0.50Beat
Apr 2, 2025-$0.43-$0.43Beat

Analyst view

Consensus price target
$10.75 ▲ +92.3%
Range $10.00 – $13.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on OBIO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.